-
News | 2019.10.16
How the influenza virus achieves efficient viral RNA replication
New insights on how subunits of the influenza virus polymerase co-evolve to ensure efficient viral RNA replication are provided by a study published October 3 in the PLOS Pathogens journal, by researchers from the Institut Pasteur and the CNRS (French National Center for Scientific Research). As the authors note, the findings could lead to novel strategies for antiviral drug development.Because...
-
News | 2019.10.15
Yersinia – a novel genomic tool for identifying strains
The Yersinia genus covers a vast range of bacteria that are distinguished by criteria such as whether or not they are able to cause disease (their pathogenicity). For instance, Yersinia pestis causes plague, while the bacteria Yersinia enterocolitica and Yersinia pseudotuberculosis are responsible for bowel diseases. Researchers at the Institut Pasteur have developed a new genomic analysis method...
-
News | 2019.10.11
EDF Group Foundation supports the Institut Pasteur and the DIVA project
During its current term, the EDF Group Foundation has chosen to support an Institut Pasteur team working on the DIVA project. This project aims to revolutionize the analysis and visualization of all medical imaging data. The aim is to develop a novel software platform that integrates data from medical imaging or microscopy to enable physicians and scientists to process and visualize images. The...
-
Article | 2019.10.21
Bordet Class (2019-2022)
Ph.D. StudentUndergraduate StudiesLaboratoryThesis AdvisorLab HeadDoctoral SchoolPh.D. ProjectPPU - studentsAICHER, Sophie-MarieImperial College London, London, United Kingdom Viral Genomics and vaccinationNolwenn JouvenetFrédéric TangyBioSPC ED 562 Human and avian antiviral response to zoonotic RNA virusesCOSTREIE, Maria-MirunaUniversity of Glasgow, Glasgow, ScotlandDynamic...
-
Document de presse | 2019.10.22
A blood factor involved in weight loss and aging
Aging is a process that affects all functions of the human body, particularly brain function. However, aging can be delayed through lifestyle changes (physical exercise, restricting calorie intake, etc.). Researchers at the Institut Pasteur and CNRS have elucidated the properties of a molecule in the blood – GDF11 – whose mechanisms were previously unknown. In a mouse model, they showed that this...
-
Reportage | 2019.10.21
Southeast Asia faces the rise of emerging diseases
Continuous economic development in Southeast Asia has left a considerable impact on ecosystems, unleashing infectious diseases like dengue fever and leptospirosis. A program coordinated by the Institut Pasteur, with the support of AFD, is identifying the risk factors behind these diseases and improving diagnosis capacities to provide better treatment.
-
CNR/CCOMS | 2019.10.25
Biological Resource Center of Institut Pasteur (CRBIP)
-
CNR/CCOMS | 2019.10.25
About CRBIP
INTRODUCTIONCreated in 2001, the Centre de Ressources Biologiques de l'Institut Pasteur (CRBIP) is a biobank infrastructure, with a transversal function, which gathers collections of microbial and human specimens from Institut Pasteur. Its missions are to preserve and provide worldwide microbial and human bioresources from historical or recent collections, for research, training and quality...
-
Document de presse | 2019.09.16
International inaugural congress of the Hearing Institute
To mark the occasion of the creation of the Hearing Institute, an Institut Pasteur center dedicated to research into auditory neuroscience, Professor Christine Petit is organizing an inaugural scientific congress at the Collège de France on September 16 and 17, 2019, in partnership with the Fondation pour l’Audition and Inserm. This international scientific meeting will mark the birth of the...
-
Reportage | 2019.10.29
Photonic BioImaging – high-resolution microscopy in the era of artificial intelligence
New advanced microscopy techniques open up numerous possibilities, such as observing the mechanisms of living systems to elucidate and combat diseases like cancer, HIV and brain tumors, and identifying molecules which can be used in the development of new drugs. But microscopy tools are extremely expensive. So in the 2000s, the Institut Pasteur decided to set up a series of technological...
